These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clinical evaluation of methyprylon (noludar) as a preanaesthetic sedative hypnotic. DOBKIN AB; WYANT GM Can Anaesth Soc J; 1957 Jan; 4(1):27-36. PubMed ID: 13396638 [No Abstract] [Full Text] [Related]
3. A new, mild sedative-hypnotic, a piperidine derivative (noludar). BRANDMAN O; CONIARIS J; KELLER HE J Med Soc N J; 1955 May; 52(5):246-53. PubMed ID: 14368200 [No Abstract] [Full Text] [Related]
4. [Experiences with a barbiturate-free hypnotic and sedative in small children. Clinical and electroencephalographic research on 2,4-dioxo-3,3-diethyl-5-methylpiperidine (Noludar)]. HORSTMANN W Munch Med Wochenschr; 1962 Mar; 104():603-8. PubMed ID: 14449058 [No Abstract] [Full Text] [Related]
5. [Noludar, a new sedative]. LANGE HJ Med Klin; 1956 Feb; 51(8):303-4. PubMed ID: 13308742 [No Abstract] [Full Text] [Related]
6. Fatal poisoning with methyprylon (Noludar), a nonbarbiturate sedative. Reidt WU N Engl J Med; 1956 Aug; 255(5):231-2. PubMed ID: 13348845 [No Abstract] [Full Text] [Related]
7. The use of a non-barbiturate hypnotic, methyprylone ("noludar") in general practice. BELL JD J Ir Med Assoc; 1959 Sep; 45():82-3. PubMed ID: 13798503 [No Abstract] [Full Text] [Related]
8. A study of hypnotic drugs in patients with chronic diseases; comparative efficacy of placebo; methyprylon (noludar) meprobmate (miltown, equanil) pentobarbial; phenobarbital; secobarbital. LASAGNA L J Chronic Dis; 1956 Feb; 3(2):122-33. PubMed ID: 13295345 [No Abstract] [Full Text] [Related]
9. Clinical experiences with methyprylon, a nonbarbiturate sedative and hypnotic drug. BILLOW BW; STEINBERG M; LUPINI SB; ROTHMAN H; CAREY R; PALEY SS; MARTORELLA FJ Int Rec Med; 1960 May; 173():288-92. PubMed ID: 13800724 [No Abstract] [Full Text] [Related]
10. The use of noludar in pediatric electroencephalography. WINFIELD DL; HUGHES JG Electroencephalogr Clin Neurophysiol; 1957 Nov; 9(4):713-5. PubMed ID: 13480244 [No Abstract] [Full Text] [Related]
11. Methyprylon, a new sedative and hypnotic drug. CASS LJ; FREDERIK WS; ANDOSCA JB N Engl J Med; 1955 Oct; 253(14):586-91. PubMed ID: 13266000 [No Abstract] [Full Text] [Related]
12. Addiction to "Noludar"; a report of two cases. JENSEN GR N Z Med J; 1960 Sep; 59():431-2. PubMed ID: 13789900 [No Abstract] [Full Text] [Related]
13. Effects of methyprylon (noludar) and phenobarbital on the electrocardiogram. SCHAFFER AI; SEEGERS W J Am Geriatr Soc; 1956 Nov; 4(11):1078-9. PubMed ID: 13376291 [No Abstract] [Full Text] [Related]
14. [Treatment of depressions in general practice with noludar]. HERZOG M Ther Umsch; 1955 Sep; 12(6):86-7. PubMed ID: 13281821 [No Abstract] [Full Text] [Related]
15. [Treatment of insomnia with a new hypogenic, noludar Roche]. THUER W Praxis; 1956 May; 45(18):416-8. PubMed ID: 13335697 [No Abstract] [Full Text] [Related]
16. [Experiences with methylprylon ("noludar", Roche) in 412 surgical patients]. CATTANEO AD Minerva Anestesiol; 1959 Jul; 25():271-80. PubMed ID: 13808446 [No Abstract] [Full Text] [Related]
17. Darvon, Dieldrin and Noludar. CHAPMAN JE; LEWIS CE J Kans Med Soc; 1962 Jun; 63():228-9. PubMed ID: 13878181 [No Abstract] [Full Text] [Related]
18. [IR DEMONSTRATION OF REVONAL AND NOLUDAR IN CADAVERS]. PAULUS W; GOENECHEA S Arch Toxikol; 1963 Dec; 20():194-6. PubMed ID: 14114480 [No Abstract] [Full Text] [Related]
19. Clinical studies on toxicity and on hypnotic and sedative effects of RO 1-6463*, noludar (3,3-diethyl-2,4-dioxo-5-methylpiperidine). LOUGHLIN EH; MULLIN WG; SCHWIMMER J; SCHWIMMER M Int Rec Med Gen Pract Clin; 1955 Feb; 168(2):52-60. PubMed ID: 14353568 [No Abstract] [Full Text] [Related]
20. [Hypnotic effect of 3-phenyl-3-ethyl-glutarimide. I. Possibility of synergistic action]. CASENTINI S; MARIANI L Boll Soc Ital Biol Sper; 1956 Jun; 32(6):487-9. PubMed ID: 13374137 [No Abstract] [Full Text] [Related] [Next] [New Search]